Abstract
Issues concerning the optimal salvage treatment in patients with germ cell tumors are for the most part controversial. As the majority of patients will suffer systemic relapses, chemotherapy will remain the mainstay of any salvage treatment. However, the question of whether to use conventional-dose or high-dose chemotherapy (HDCT) immediately arises. Prognostic factors have recently been recognized as an aid in this decision. However, as reliable data are lacking for many clinical scenarios, the salvage treatment of germ-cell tumors continues to be a therapeutic challenge.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beyer, J., Rick, O., Siegert, W. et al. Salvage chemotherapy in relapsed germ cell tumors. World J Urol 19, 90–93 (2001). https://doi.org/10.1007/PL00007095
Issue Date:
DOI: https://doi.org/10.1007/PL00007095